关注
Samia Mora
Samia Mora
Professor, Harvard Medical School
在 partners.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Heart disease and stroke statistics—2017 update: a report from the American Heart Association
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
circulation 135 (10), e146-e603, 2017
266152017
Discovery and refinement of loci associated with lipid levels
CJ Willer, EM Schmidt, S Sengupta, GM Peloso, S Gustafsson, S Kanoni, ...
Nature genetics 45 (11), 1274, 2013
3076*2013
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
S Bansal, JE Buring, N Rifai, S Mora, FM Sacks, PM Ridker
Jama 298 (3), 309-316, 2007
21832007
Vitamin D supplements and prevention of cancer and cardiovascular disease
JAE Manson, NR Cook, IM Lee, W Christen, SS Bassuk, S Mora, ...
New England Journal of Medicine 380 (1), 33-44, 2019
17272019
Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms
S Mora, N Cook, JE Buring, PM Ridker, IM Lee
Circulation 116 (19), 2110-2118, 2007
13902007
Common variants associated with plasma triglycerides and risk for coronary artery disease
R Do, CJ Willer, EM Schmidt, S Sengupta, C Gao, GM Peloso, ...
Nature genetics 45 (11), 1345-1352, 2013
10632013
Association of LDL cholesterol, non–HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis
SM Boekholdt, BJ Arsenault, S Mora, TR Pedersen, JC LaRosa, PJ Nestel, ...
Jama 307 (12), 1302-1309, 2012
10462012
Marine n− 3 fatty acids and prevention of cardiovascular disease and cancer
JAE Manson, NR Cook, IM Lee, W Christen, SS Bassuk, S Mora, ...
New England Journal of Medicine 380 (1), 23-32, 2019
10342019
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint …
BG Nordestgaard, A Langsted, S Mora, G Kolovou, H Baum, E Bruckert, ...
European heart journal 37 (25), 1944-1958, 2016
9102016
Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials
SM Boekholdt, GK Hovingh, S Mora, BJ Arsenault, P Amarenco, ...
Journal of the American College of Cardiology 64 (5), 485-494, 2014
8472014
Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study
S Mora, RF Redberg, Y Cui, MK Whiteman, JA Flaws, AR Sharrett, ...
Jama 290 (12), 1600-1607, 2003
7962003
Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women
S Mora, JD Otvos, N Rifai, RS Rosenson, JE Buring, PM Ridker
Circulation 119 (7), 931-939, 2009
755*2009
Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children
TO Kilpeläinen, L Qi, S Brage, SJ Sharp, E Sonestedt, E Demerath, ...
PLoS medicine 8 (11), e1001116, 2011
7452011
Lipoprotein (a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
F Kronenberg, S Mora, ESG Stroes, BA Ference, BJ Arsenault, L Berglund, ...
European heart journal 43 (39), 3925-3946, 2022
6902022
LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA)
S Mora, M Szklo, JD Otvos, P Greenland, BM Psaty, DC Goff Jr, ...
Atherosclerosis 192 (1), 211-217, 2007
6242007
Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease
P Zanoni, SA Khetarpal, DB Larach, WF Hancock-Cerutti, JS Millar, ...
Science 351 (6278), 1166-1171, 2016
5952016
Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women
S Mora, IM Lee, JE Buring, PM Ridker
Jama 295 (12), 1412-1419, 2006
5852006
Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events
S Mora, N Rifai, JE Buring, PM Ridker
Circulation 118 (10), 993-1001, 2008
5442008
Baseline and on-statin treatment lipoprotein (a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials
P Willeit, PM Ridker, PJ Nestel, J Simes, AM Tonkin, TR Pedersen, ...
The Lancet 392 (10155), 1311-1320, 2018
5172018
Lipoprotein (a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an …
AV Khera, BM Everett, MP Caulfield, FM Hantash, J Wohlgemuth, ...
Circulation 129 (6), 635-642, 2014
5072014
系统目前无法执行此操作,请稍后再试。
文章 1–20